scorecardresearch
Business Today
Subscribe
PMS Today US News India UPSTART Weather BT Shorts NRI Education Election
BT Golf BT Mindrush BT Best Banks
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
  • BT tech today
  • BT 500 wealth creators summit
  • Economic Indicators
News
Markets
Stocks
Alembic Pharmaceuticals Ltd

Feedback
Alembic Pharmaceuticals Ltd

Alembic Pharmaceuticals Ltd (APLLTD) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 99,014
Mar 17, 2025 15:47 IST-
  • NSE
  • BSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹822.00
₹-5.35 (0.65%)
₹818 Low
Today’s Performance
₹838.7 High
₹725.2 Low
52 Week’s Performance
₹1303.9 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day -0.65%
  • 1 Week 1.97%
  • 1 Month 0.19%
  • 3 Months -22.10%
  • 6 Months -31.52%
  • 1 Year -10.01%
  • 3 Years 4.32%
  • 5 Years 7.58%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 2.00
  • Beta 0.53
  • 52-Week Low (₹) 725.20
  • 52-Week High (₹) 1,303.90
  • Price-to-Book (X)* 3.33
  • Dividend Yield (%) 1.33
  • Price-to-Earnings (P/E) (X)* 26.91
  • Earnings Per Share (₹) 30.77
  • Sector Price Earning (X)* 32.46
  • Market Cap (₹ Cr.)* 16,262.65
  • * Vaues as of last close price

COMPETITORS

BT TV

Gold Outlook: Expert's View On Gold As A Hedge Amid Trump's Tariffs And Currency Wars 1:13 Gold Outlook: Expert's View On Gold As A Hedge Amid Trump's Tariffs And Currency Wars
NASA’s Stranded Astronauts Sunita Williams, Butch Wilmore Set For Long-Awaited Homecoming 3:41 NASA’s Stranded Astronauts Sunita Williams, Butch Wilmore Set For Long-Awaited Homecoming
US Intelligence Chief Tulsi Gabbard: Confident Of India-US Trade Ties 1:38 US Intelligence Chief Tulsi Gabbard: Confident Of India-US Trade Ties
BT Mindrush: Elevating Leadership And Innovation In Indian Business 0:52 BT Mindrush: Elevating Leadership And Innovation In Indian Business
Gautam Adani Reviews Navi Mumbai Airport  Progress | Confirms Airport Date 2:08 Gautam Adani Reviews Navi Mumbai Airport Progress | Confirms Airport Date
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

  • NSE
  • BSE
Oct 11, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 184251
  • Average Price ₹611.25
Oct 11, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 25903
  • Average Price ₹611.25
Oct 11, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 25903
  • Average Price ₹611.25
Oct 11, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 184251
  • Average Price ₹611.25
Sep 19, 2022 PURCHASE
ISHARES MSCI INDIA SMALL-CAP ETF
  • Qty 27364
  • Average Price ₹609.90
Sep 19, 2022 PURCHASE
ISHARES CORE MSCI EMERGING MARKETS ETF
  • Qty 194642
  • Average Price ₹609.90
Sep 19, 2022 Sell
ISHARES INDIA SC MAURITIUS COMPANY
  • Qty 27364
  • Average Price ₹609.90
Sep 19, 2022 Sell
ISHARES CORE EMERGING MARKETS MAURITIUS CO
  • Qty 194642
  • Average Price ₹609.90
Mar 24, 2017 PURCHASE
SIERRA INVESTMENTS LIMITED
  • Qty 170000
  • Average Price ₹602.00
Mar 24, 2017 PURCHASE
SHRENO LIMITED
  • Qty 530000
  • Average Price ₹602.00
*Single trade that involves transaction of a minimum quantity of 5 lakh shares or a minimum value of ₹ 10 crore.
Mar 23, 2017 Sell
VIRAMYA PACKLIGHT LLP
  • Qty 1000000
  • Average Price ₹595.00
Mar 23, 2017 PURCHASE
SHRENO LIMITED
  • Qty 1000000
  • Average Price ₹595.00
Mar 23, 2017 Sell
VIRAMYA PACKLIGHT LLP
  • Qty 1000000
  • Average Price ₹595.00
Mar 23, 2017 PURCHASE
SHRENO LIMITED
  • Qty 1000000
  • Average Price ₹595.00
*Involves transaction of at least 0.5% of the listed shares of a company.

FAQ’S

What was Alembic Pharmaceuticals Ltd share price previously?
Alembic Pharmaceuticals Ltd share price was down by -0.65% from the previous closing price of ₹827.35.
Who are peers of Alembic Pharmaceuticals Ltd?
The peers of Alembic Pharmaceuticals Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories Ltd, Cipla Ltd, Torrent Pharmaceuticals Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd,
Who is/are the promoter/promoters of Alembic Pharmaceuticals Ltd?
The promotor/promotors of Alembic Pharmaceuticals Ltd are Chirayu R Amin, Rajkumar Baheti, Pranav Amin, Shaunak Amin, Archana Hingorani, Ashok Barat, Manisha Saraf, Jai S Diwanji, Manish Kejriwal, Geeta Goradia.
What has been 52-week high of Alembic Pharmaceuticals Ltd stocks?
The highest price of Alembic Pharmaceuticals Ltd stock is ₹1,303.90 in the last 52-week.
What is the share price of Alembic Pharmaceuticals Ltd (APLLTD) today on NSE?
As on Mar 17, 2025, Alembic Pharmaceuticals Ltd (APLLTD)’s share price on NSE is Rs 822
What is the market cap of Alembic Pharmaceuticals Ltd (APLLTD?)
The current market capitalisation of Alembic Pharmaceuticals Ltd (APLLTD) is 16,262.65 crores
What is Alembic Pharmaceuticals Ltd Share symbol?
The symbol of Alembic Pharmaceuticals Ltd is APLLTD.
What is the PE ratio of Alembic Pharmaceuticals Ltd (APLLTD)?
The current PE ratio of Alembic Pharmaceuticals Ltd (APLLTD) is 26.91.
What is the PB ratio of Alembic Pharmaceuticals Ltd (APLLTD)?
The current PB ratio of Alembic Pharmaceuticals Ltd (APLLTD) is 3.33.
Today’s High & Low share prices of Alembic Pharmaceuticals Ltd (APLLTD) on NSE?
Today, the share price of Alembic Pharmaceuticals Ltd (APLLTD) on NSE touched a high of Rs 838.7 and a low of Rs 818
What price did Alembic Pharmaceuticals Ltd (APLLTD) shares open on the NSE today?
On NSE, the share price of Alembic Pharmaceuticals Ltd (APLLTD) opened at Rs 827.35
What is the 52-week high of Alembic Pharmaceuticals Ltd (APLLTD)?
The 52-week high price of Alembic Pharmaceuticals Ltd (APLLTD) is Rs 1303.9
What is the 52-week low of Alembic Pharmaceuticals Ltd (APLLTD) ?
The 52-week low price of Alembic Pharmaceuticals Ltd (APLLTD) is Rs 725.2

ABOUT ALEMBIC PHARMA

Alembic Pharmaceuticals Ltd, incorporated in the year 2010, has its registered office in Alembic Road, Vadodara, Gujarat, 390003, 91-0265-2280550, 91-0265-2282506. The main industry in which Alembic Pharmaceuticals Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Alembic Pharmaceuticals Ltd is/are K C Mehta & Co LLP. In the main management, Chirayu R Amin is chairman and Manisha Saraf is the company secretary for Alembic Pharmaceuticals Ltd.

  • CRA Chirayu R Amin Chairman & CEO
  • RB Rajkumar Baheti Director (Finance) & CFO
  • PA Pranav Amin Managing Director
  • SA Shaunak Amin Managing Director
  • AH Archana Hingorani Independent Director
  • AB Ashok Barat Independent Director
  • MS Manisha Saraf Company Sec. & Compli. Officer
  • JSD Jai S Diwanji Independent Director
  • MK Manish Kejriwal Independent Director
  • GG Geeta Goradia Independent Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.

Advertisement